Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Natera Inc (NQ: NTRA ) 120.65 -1.75 (-1.43%) Streaming Delayed Price Updated: 2:07 PM EDT, Oct 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Natera Inc < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Top 5 Health Care Stocks That May Collapse In November November 17, 2023 As of Nov. 17, 2023, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. Via Benzinga Natera Announces Real-World Data Collaboration with Merck November 14, 2023 From Natera, Inc. Via Business Wire Analyst Expectations for Natera's Future November 09, 2023 Via Benzinga Disney, Twilio, TransDigm, Marathon Digital And Other Big Stocks Moving Higher On Thursday November 09, 2023 U.S. stocks traded mostly lower, with the Dow Jones falling around 75 points on Thursday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Analyst Ratings for Natera October 16, 2023 Via Benzinga The Latest Analyst Ratings for Natera August 08, 2023 Via Benzinga Natera Reports Third Quarter 2023 Financial Results November 08, 2023 From Natera, Inc. Via Business Wire Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast Cancer November 08, 2023 From Natera, Inc. Via Business Wire Natera to Participate in November Investor Conferences November 07, 2023 From Natera, Inc. Via Business Wire NATERA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Natera, Inc. - NTRA November 03, 2023 From Kahn Swick & Foti, LLC Via Business Wire Natera’s Landmark RenaCARE Study Demonstrates Significant Diagnostic and Clinical Utility of Renasight™ in Chronic Kidney Disease November 02, 2023 From Natera, Inc. Via Business Wire Bull Of The Day: NeoGenomics October 24, 2023 NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer. Via Talk Markets Updated Data from CIRCULATE-Japan Presented at ESMO 2023 Reinforces Signatera’s Prognostic and Predictive Value in Analysis of 2,500+ Colorectal Cancer Patients October 22, 2023 From Natera, Inc. Via Business Wire Natera to Report its Third Quarter 2023 Results on November 8 October 20, 2023 From Natera, Inc. Via Business Wire Natera Recognized on U.S. News & World Report’s 2024 Best Companies to Work for in Healthcare Ranking October 19, 2023 From Natera, Inc. Via Business Wire Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 October 17, 2023 EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END Via FinancialNewsMedia Natera to Present New Signatera™ MRD Data at ESMO 2023, Featuring Large, Updated Analysis from CIRCULATE-Japan Study October 16, 2023 From Natera, Inc. Via Business Wire NATERA INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Natera, Inc. - NTRA October 06, 2023 From Kahn Swick & Foti, LLC Via Business Wire New MRD Publication in Unresectable Stage I-III Lung Cancer Demonstrates Signatera’s Ability to Risk Stratify and Detect Progression Early October 04, 2023 From Natera, Inc. Via Business Wire Supreme Court Denies CareDx Request for Appeal in Patent Case with Natera October 03, 2023 From Natera, Inc. Via Business Wire Natera Submits First PMA Module to the FDA for Signatera™ October 02, 2023 From Natera, Inc. Via Business Wire Natera Announces Senior Leadership Appointments September 18, 2023 From Natera, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 September 28, 2023 Via Benzinga Natera Announces Expanded I-SPY 2 Collaboration to Evaluate Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting September 14, 2023 From Natera, Inc. Via Business Wire Natera Announces Pricing of $250 Million Follow-On Offering September 07, 2023 From Natera, Inc. Via Business Wire Natera Launches Proposed Follow-On Offering September 06, 2023 From Natera, Inc. Via Business Wire Natera to Participate in Upcoming Investor Conferences September 01, 2023 From Natera, Inc. Via Business Wire Natera’s Prospera™ Lung Transplant Assessment Test Granted Medicare Coverage August 16, 2023 From Natera, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's Intraday Session August 04, 2023 Via Benzinga Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session August 04, 2023 Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.